Abbott Laboratories Current Ratio 2010-2023 | ABT
Abbott Laboratories Current Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets | Current Liabilities | Current Ratio |
2023-12-31 | $22.67B | $13.84B | 1.64 |
2023-09-30 | $22.66B | $13.04B | 1.74 |
2023-06-30 | $23.51B | $14.35B | 1.64 |
2023-03-31 | $24.38B | $14.53B | 1.68 |
2022-12-31 | $25.22B | $15.49B | 1.63 |
2022-09-30 | $24.85B | $13.37B | 1.86 |
2022-06-30 | $24.96B | $12.39B | 2.01 |
2022-03-31 | $23.43B | $12.65B | 1.85 |
2021-12-31 | $24.24B | $13.11B | 1.85 |
2021-09-30 | $23.49B | $12.87B | 1.83 |
2021-06-30 | $22.63B | $12.61B | 1.79 |
2021-03-31 | $21.82B | $12.46B | 1.75 |
2020-12-31 | $20.44B | $11.91B | 1.72 |
2020-09-30 | $17.39B | $10.26B | 1.70 |
2020-06-30 | $17.22B | $10.96B | 1.57 |
2020-03-31 | $15.50B | $10.81B | 1.43 |
2019-12-31 | $15.67B | $10.86B | 1.44 |
2019-09-30 | $16.12B | $10.49B | 1.54 |
2019-06-30 | $15.20B | $9.06B | 1.68 |
2019-03-31 | $14.41B | $9.11B | 1.58 |
2018-12-31 | $14.63B | $9.01B | 1.62 |
2018-09-30 | $18.20B | $12.78B | 1.42 |
2018-06-30 | $14.12B | $8.95B | 1.58 |
2018-03-31 | $14.96B | $9.01B | 1.66 |
2017-12-31 | $20.15B | $8.91B | 2.26 |
2017-09-30 | $21.38B | $7.94B | 2.69 |
2017-06-30 | $19.98B | $6.80B | 2.94 |
2017-03-31 | $19.33B | $6.65B | 2.91 |
2016-12-31 | $26.78B | $6.66B | 4.02 |
2016-09-30 | $12.98B | $8.32B | 1.56 |
2016-06-30 | $12.99B | $8.67B | 1.50 |
2016-03-31 | $12.41B | $8.39B | 1.48 |
2015-12-31 | $14.16B | $9.19B | 1.54 |
2015-09-30 | $15.89B | $8.76B | 1.82 |
2015-06-30 | $21.13B | $9.19B | 2.30 |
2015-03-31 | $19.99B | $9.21B | 2.17 |
2014-12-31 | $13.56B | $10.47B | 1.30 |
2014-09-30 | $16.46B | $10.82B | 1.52 |
2014-06-30 | $18.26B | $9.85B | 1.85 |
2014-03-31 | $17.93B | $10.19B | 1.76 |
2013-12-31 | $19.25B | $9.51B | 2.03 |
2013-09-30 | $19.75B | $11.33B | 1.74 |
2013-06-30 | $19.83B | $10.92B | 1.82 |
2013-03-31 | $19.10B | $10.41B | 1.84 |
2012-12-31 | $31.32B | $13.28B | 2.36 |
2012-09-30 | $27.26B | $16.29B | 1.67 |
2012-06-30 | $26.26B | $17.12B | 1.53 |
2012-03-31 | $25.60B | $16.79B | 1.53 |
2011-12-31 | $23.77B | $15.48B | 1.54 |
2011-09-30 | $23.09B | $15.41B | 1.50 |
2011-06-30 | $24.13B | $15.84B | 1.52 |
2011-03-31 | $23.65B | $17.23B | 1.37 |
2010-12-31 | $22.32B | $17.26B | 1.29 |
2010-09-30 | $19.45B | $15.58B | 1.25 |
2010-06-30 | $19.92B | $14.69B | 1.36 |
2010-03-31 | $17.69B | $15.18B | 1.17 |
2009-12-31 | $23.31B | $13.05B | 1.79 |
2009-09-30 | $21.42B | $12.53B | 1.71 |
2009-06-30 | $19.63B | $12.04B | 1.63 |
2009-03-31 | $18.01B | $11.77B | 1.53 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $196.909B | $40.109B |
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Stryker (SYK) | United States | $136.478B | 33.84 |
Medtronic (MDT) | Ireland | $115.414B | 16.34 |
EssilorLuxottica (ESLOY) | France | $103.810B | 0.00 |
Boston Scientific (BSX) | United States | $100.864B | 33.47 |
Lonza Group Ag (LZAGY) | Switzerland | $44.257B | 0.00 |
Haleon (HLN) | United Kingdom | $39.385B | 30.46 |
ResMed (RMD) | United States | $28.878B | 28.87 |
Terumo (TRUMY) | Japan | $27.930B | 39.32 |
Zimmer Biomet Holdings (ZBH) | United States | $27.196B | 17.54 |
Baxter (BAX) | United States | $21.679B | 15.81 |
Koninklijke Philips (PHG) | Netherlands | $18.879B | 15.06 |
Insulet (PODD) | United States | $11.830B | 62.20 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.515B | 0.00 |
Demant (WILYY) | Denmark | $11.278B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.969B | 29.70 |
BellRing Brands (BRBR) | United States | $7.702B | 41.41 |
Haemonetics (HAE) | United States | $4.271B | 21.84 |
Perrigo (PRGO) | Ireland | $4.263B | 12.19 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Lantheus Holdings (LNTH) | United States | $4.145B | 10.70 |
Envista Holdings (NVST) | United States | $3.697B | 14.09 |
Prestige Consumer Healthcare (PBH) | United States | $3.606B | 17.05 |
Neogen (NEOG) | United States | $3.347B | 32.21 |
QuidelOrtho (QDEL) | United States | $3.226B | 11.71 |
Green Thumb Industries (GTBIF) | United States | $3.155B | 100.00 |
ICU Medical (ICUI) | United States | $2.484B | 18.71 |
TG Therapeutics (TGTX) | United States | $2.404B | 778.50 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.157B | 0.00 |
Verano Holdings (VRNOF) | United States | $2.151B | 0.00 |
Owens & Minor (OMI) | United States | $2.141B | 20.55 |
InMode (INMD) | Israel | $1.780B | 9.22 |
National Vision Holdings (EYE) | United States | $1.720B | 53.56 |
Agios Pharmaceuticals (AGIO) | United States | $1.636B | 0.00 |
AdaptHealth (AHCO) | United States | $1.510B | 11.36 |
LeMaitre Vascular (LMAT) | United States | $1.499B | 49.78 |
AtriCure (ATRC) | United States | $1.458B | 0.00 |
Warby Parker (WRBY) | United States | $1.303B | 0.00 |
MacroGenics (MGNX) | United States | $0.934B | 0.00 |
Quanterix (QTRX) | United States | $0.873B | 0.00 |
Canopy Growth (CGC) | Canada | $0.870B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.836B | 0.00 |
Evolus (EOLS) | United States | $0.811B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.716B | 15.47 |
TerrAscend (TSNDF) | Canada | $0.571B | 0.00 |
Valneva SE (VALN) | France | $0.553B | 0.00 |
Jin Medical (ZJYL) | China | $0.543B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.529B | 11.46 |
PetIQ (PETQ) | United States | $0.513B | 19.17 |
OraSure Technologies (OSUR) | United States | $0.470B | 7.77 |
ZimVie (ZIMV) | United States | $0.442B | 27.18 |
Biote (BTMD) | United States | $0.438B | 4.16 |
Surmodics (SRDX) | United States | $0.410B | 44.31 |
Zynex (ZYXI) | United States | $0.405B | 46.59 |
Viemed Healthcare (VMD) | United States | $0.364B | 36.08 |
Cerus (CERS) | United States | $0.325B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.322B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.259B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.252B | 15.36 |
TriSalus Life Sciences (TLSI) | United States | $0.248B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.216B | 0.00 |
Omeros (OMER) | United States | $0.215B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.213B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.189B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.183B | 0.00 |
High Tide (HITI) | Canada | $0.163B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.146B | 0.00 |
Fonar (FONR) | United States | $0.138B | 11.84 |
InterCure (INCR) | Israel | $0.115B | 19.46 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.114B | 0.00 |
FitLife Brands (FTLF) | United States | $0.106B | 20.70 |
MariMed (MRMD) | United States | $0.102B | 0.00 |
Safety Shot (SHOT) | United States | $0.094B | 0.00 |
Chimerix (CMRX) | United States | $0.090B | 0.00 |
Veru (VERU) | United States | $0.089B | 0.00 |
Brainsway (BWAY) | Israel | $0.087B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.080B | 43.99 |
Zevia PBC (ZVIA) | United States | $0.075B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.25 |
Cytosorbents (CTSO) | United States | $0.050B | 0.00 |
Apyx Medical (APYX) | United States | $0.049B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Bright Green (BGXX) | United States | $0.047B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.045B | 0.00 |
Modular Medical (MODD) | United States | $0.043B | 0.00 |
ImmuCell (ICCC) | United States | $0.041B | 0.00 |
United-Guardian (UG) | United States | $0.036B | 13.85 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.024B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.020B | 0.00 |
Flora Growth (FLGC) | United States | $0.018B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |